$0.0615
-0.0045[-6.78%]
At close: Apr 18
Aridis Pharmaceuticals
(OTCQB:ARDS)Aridis Pharmaceuticals Stock (OTC:ARDS), Earnings Estimates, EPS, and Revenue
Aridis Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 3
EPS
$0.000
Quarterly Revenue
$417K
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$19.6M
Analyze the earnings history of Aridis Pharmaceuticals using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 06/06/2024 | PM | ARDS | Q1 | -$0.22 | — | — | — | $1.08M | — | — | — | Get Alert |
| 05/20/2024 | PM | ARDS | Q4 | -$0.27 | — | — | — | $1.21M | — | — | — | Get Alert |
| 11/03/2023 | PM | ARDS | Q3 | -$0.47 | — | $0.00 | — | $399.00K | — | $417.00K | — | Get Alert |
| 09/14/2023 | PM | ARDS | Q2 | -$0.45 | — | $0.33 | — | $292.00K | — | $19.65M | — | Get Alert |
| 06/08/2023 | PM | ARDS | Q1 | -$0.44 | — | -$0.22 | — | $1.19M | — | $1.08M | — | Get Alert |
| 05/22/2023 | PM | ARDS | Q4 | -$0.92 | — | -$0.27 | — | $570.00K | — | $1.21M | — | Get Alert |
| 11/21/2022 | PM | ARDS | Q3 | -$1.94 | -$0.17 | -$0.47 | -176.47% | $515.00K | $7.47M | $399.00K | -94.66% | Get Alert |
| 08/16/2022 | PM | ARDS | Q2 | -$0.55 | -$0.06 | -$0.45 | -650.00% | $33.00K | $10.46M | $292.00K | -97.21% | Get Alert |
| 05/16/2022 | PM | ARDS | Q1 | -$0.77 | -$0.51 | -$0.44 | 13.73% | $0.00 | $2.00M | $1.19M | -40.65% | Get Alert |
| 03/31/2022 | PM | ARDS | Q4 | -$0.59 | -$0.41 | -$0.92 | -124.39% | $0.00 | $1.90M | $570.00K | -70.00% | Get Alert |
| 11/10/2021 | PM | ARDS | Q3 | -$0.65 | — | -$1.94 | — | $0.00 | — | $515.00K | — | Get Alert |
| 08/12/2021 | PM | ARDS | Q2 | -$0.47 | -$0.62 | -$0.55 | 11.29% | $1.00M | $300.00K | $33.00K | -89.00% | Get Alert |
| 05/11/2021 | PM | ARDS | Q1 | -$0.73 | -$0.62 | -$0.77 | -24.19% | $0.00 | — | $0.00 | — | Get Alert |
| 03/30/2021 | PM | ARDS | Q4 | -$0.62 | — | -$0.59 | — | $0.00 | — | $0.00 | — | Get Alert |
| 11/20/2020 | PM | ARDS | Q3 | -$0.87 | -$0.63 | -$0.65 | -3.17% | $0.00 | $310.00K | $0.00 | -100.00% | Get Alert |
| 08/11/2020 | PM | ARDS | Q2 | -$1.03 | -$0.74 | -$0.47 | 36.49% | $0.00 | $270.00K | $1.00M | 270.37% | Get Alert |
| 05/12/2020 | PM | ARDS | Q1 | -$0.99 | — | -$0.73 | — | $1.02M | — | $0.00 | — | Get Alert |
| 04/08/2020 | PM | ARDS | Q4 | -$0.67 | — | -$0.62 | — | $1.39M | — | $0.00 | — | Get Alert |
| 11/13/2019 | PM | ARDS | Q3 | -$1.97 | — | -$0.87 | — | $1.02M | — | $0.00 | — | Get Alert |
FAQ
When is Aridis Pharmaceuticals (OTCQB:ARDS) reporting earnings?
Aridis Pharmaceuticals (ARDS) is scheduled to report earnings on June 6, 2024. The last reported earnings were for reported on November 3, 2023 for Q3.
What were the latest earnings per share (EPS) for Aridis Pharmaceuticals (OTCQB:ARDS)?
The Actual EPS was $0.00, which hit the estimate of $0.00.
What were Aridis Pharmaceuticals’s (OTCQB:ARDS) revenues?
The Actual Revenue was $417K, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.